Category - Precision medicine

Geisinger awarded $3.6 million to study genetics of cancer

Seven Bridges Announces Initial Close of Series C Funding from New Strategic Investor to Accelerate Product Development and Commercial Growth

BC Platforms Partners with TripleBlind to Power Federated Artificial Intelligence (AI) Data Privacy Approaches

Invitae joins NIH-sponsored study aimed at improving understanding of the links between genes and cancer, heart disease and other conditions

Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwide

The Medical Research Community Has a Duty to Be Racially And Ethnically Inclusive in Their Study Demographics

Genomenon Completes $5.3M Financing Round

Konica Minolta Precision Medicine collaborates with AWS to create the next generation of precision diagnostics

Foundation Medicine and InformedDNA® Collaborate to Improve Access to Genetic Counseling for Advanced Cancer Patients

Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services

NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference

Genomics plc completes oversubscribed $30M funding round

WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector

Human Pangenome Reference Consortium Announced Global Release of Year 1 Sequencing Data

QIAGEN announces Digital Partner Program with five initial partnerships

Copyright © 2026. enlighenbio LLC. All rights reserved.